Fierce Biotech Names Proxygen a “Fierce 15” Biotech Company of 2023
Por um escritor misterioso
Descrição
VIENNA, Austria, Aug. 28, 2023 (GLOBE NEWSWIRE) -- Proxygen, a leader in the discovery and development of molecular glue degraders, today announced that Fierce Biotech has named it as one of 2023’s “Fierce 15” biotechnology companies. The annual special report features the most innovative and promising early-stage biotechnology companies in the industry. “It is an incredible honor to be recognized as one of the Fierce 15 biotech companies for 2023,” said Bernd Boidol, Ph.D., chief executive offi
Chris Jenkins on LinkedIn: Introducing Fierce Biotech's 2023 Fierce 15
Fierce Biotech on LinkedIn: Treading where Roche and Sanofi failed
Proxygen (@ProxygenTx) / X
Chris Jenkins on LinkedIn: Gene Therapy Finds New Life in an Old Home
Jacob Perrett on LinkedIn: #analyticaldevelopment #sec
Mitchell Pease on LinkedIn: #innovation #biotech #lifesciences
Introducing Fierce Biotech's 2023 Fierce 15
Georg Winter (@georg_e_winter) / X
Jacob Perrett on LinkedIn: VC funding update: Which Boston-area
Georg Winter (@georg_e_winter) / X
Fierce Biotech on LinkedIn: Treading where Roche and Sanofi failed
Fierce Biotech's 2022 Fierce 15
de
por adulto (o preço varia de acordo com o tamanho do grupo)
